Diphtheria Market Size, Share, Regional Outlook, Competitive Strategies 2015

1. Hexa Reports Market Research Reports and Insightful Company Profiles Global Diphtheria Industry 2015 Market Share, Size, Industry Profile, Market Prize, Forecast and Overview Global Markets Direct's, 'Diphtheria - Pipeline Review, H1 2015', provides an overview of the Diphtheria's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diphtheria, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diphtheria and special features on late-stage and discontinued projects. Browse Detail Report With TOC @http://www.hexareports.com/report/diphtheria-pipeline-review- h1-2015/details Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

2. Hexa Reports Market Research Reports and Insightful Company Profiles The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides a snapshot of the global therapeutic landscape of Diphtheria The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Diphtheria and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Diphtheria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre- registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Diphtheria pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Diphtheria Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Diphtheria pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

3. Hexa Reports Market Research Reports and Insightful Company Profiles Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Request A Sample copy of This Report @ http://www.hexareports.com/sample/47455 Table Of Content Table of Contents 2 List of Tables 6 List of Figures 7 Introduction 8 Global Markets Direct Report Coverage 8 Diphtheria Overview 9 Therapeutics Development 10 Pipeline Products for Diphtheria - Overview 10 Pipeline Products for Diphtheria - Comparative Analysis 11 Diphtheria - Therapeutics under Development by Companies 12 Diphtheria - Therapeutics under Investigation by Universities/Institutes 14 Diphtheria - Pipeline Products Glance 15 Late Stage Products 15 Clinical Stage Products 16 Early Stage Products 17 Unknown Stage Products 18 Diphtheria - Products under Development by Companies 19 Diphtheria - Products under Investigation by Universities/Institutes 21 Diphtheria - Companies Involved in Therapeutics Development 22 Beijing Minhai Biotechnology Co., Ltd 22 Biological E. Limited 23 Daiichi Sankyo Company, Limited 24 GlaxoSmithKline Plc 25 Green Cross Corporation 26 Indian Immunologicals Limited 27 LG Life Sciences, Ltd. 28 Panacea Biotec Limited 29 Prometheon Pharma, LLC 30 Sanofi 31 Sanofi Pasteur SA 32 Serum Institute of India Limited 33 Sinovac Biotech Ltd. 34 Zydus Cadila Healthcare Limited 35 Diphtheria - Therapeutics Assessment 36 Assessment by Monotherapy Products 36

4. Hexa Reports Market Research Reports and Insightful Company Profiles Assessment by Combination Products 37 Assessment by Target 38 Assessment by Route of Administration 40 Assessment by Molecule Type 42 Drug Profiles 44 (diphtheria + tetanus + pertussis) vaccine - Drug Profile 44 Product Description 44 Mechanism of Action 44 R&D Progress 44 diphtheria + pertussis (acellular) + tetanus vaccine - Drug Profile 45 Product Description 45 Mechanism of Action 45 R&D Progress 45 diphtheria + pertussis (acellular) + tetanus vaccine - Drug Profile 46 Product Description 46 Mechanism of Action 46 Browse Full Report @ http://www.hexareports.com/report/diphtheria-pipeline-review-h1- 2015/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Our Blogs: http://hexareports.blogspot.in